National Cancer Institute; Notice of Closed Meetings, 36825 [2024-09639]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 87 / Friday, May 3, 2024 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Epidemiology Cohorts (U01).
Date: June 4, 2024.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W110, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Priya Srinivasan, Ph.D.,
Scientific Review Officer, Resource and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W110, Rockville, Maryland 20850,
240–276–5619, priya.srinivasan@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–12:
NCI Clinical and Translational Cancer
Research.
Date: June 14, 2024.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W526, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Viktoriya Sidorenko,
Ph.D., Scientific Review Officer, Program and
Review Extramural Staff Training Office,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W526, Rockville, Maryland
20850, 240–276–5073, viktoriya.sidorenko@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Program Project (P01) Review SEP–C.
Date: June 17–18, 2024
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W634, Rockville, Maryland 20850 (Virtual
Meeting).
VerDate Sep<11>2014
18:11 May 02, 2024
Jkt 262001
Contact Person: Michael E. Lindquist,
Ph.D., Scientific Review Officer, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W634, Rockville, Maryland 20850,
mike.lindquist@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–6: NCI
Clinical and Translational Cancer Research.
Date: June 21, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W260, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Robert F. Gahl, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9606 Medical
Center Drive, Room 7W260, Rockville,
Maryland 20850, 240–276–7869, robert.gahl@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–8: NCI
Clinical and Translational Cancer Research.
Date: June 25, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W110, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Priya Srinivasan, Ph.D.,
Scientific Review Officer, Resource and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W110, Rockville, Maryland 20850,
240–276–5619, priya.srinivasan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: April 29, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–09639 Filed 5–2–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency
Coordinating Committee Meeting
AGENCY:
National Institutes of Health,
HHS.
ACTION:
PO 00000
Notice.
Frm 00077
Fmt 4703
Sfmt 4703
36825
The Diabetes Mellitus
Interagency Coordinating Committee
(DMICC) will hold a meeting on May 30,
2024. The topic for this meeting will be
‘‘Artificial Intelligence in Diabetes
Precision Medicine: Real world data,
real world opportunities and
challenges’’. The meeting is open to the
public.
DATES: The meeting will be held on May
30, 2024 from 12:00 p.m. to 3:30 p.m.
EDT.
ADDRESSES: The meeting will be held
via the Zoom online video conferencing
platform. For details, and to register,
please contact dmicc@mail.nih.gov.
FOR FURTHER INFORMATION CONTACT: For
further information concerning this
meeting, including a draft agenda,
which will be posted when available,
see the DMICC website, https://
www.niddk.nih.gov/about-niddk/
advisory-coordinating-committees/
diabetes-mellitus-interagencycoordinating-committeedmicc?dkrd=lgdmn0022, or contact Dr.
William Cefalu, Executive Secretary of
the Diabetes Mellitus Interagency
Coordinating Committee, National
Institute of Diabetes and Digestive and
Kidney Diseases, 6707 Democracy
Boulevard, Democracy 2, Room 6037,
Bethesda, MD 20892, telephone: 301–
435–1011; email: dmicc@mail.nih.gov.
SUPPLEMENTARY INFORMATION: In
accordance with 42 U.S. Code 285c–3,
the DMICC, chaired by the National
Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) comprising
members of the Department of Health
and Human Services and other federal
agencies that support diabetes-related
activities, facilitates cooperation,
communication, and collaboration on
diabetes among government entities.
DMICC meetings, held several times a
year, provide an opportunity for
Committee members to learn about and
discuss current and future diabetes
programs in DMICC member
organizations and to identify
opportunities for collaboration. The
May 30, 2024 DMICC meeting will focus
on ‘‘Artificial Intelligence in Diabetes
Precision Medicine: Real world data,
real world opportunities and
challenges.’’
Any member of the public interested
in presenting oral comments to the
Committee should notify the contact
person listed on this notice at least 5
days in advance of the meeting.
Interested individuals and
representatives or organizations should
submit a letter of intent, a brief
description of the organization
represented, and a written copy of their
oral presentation in advance of the
SUMMARY:
E:\FR\FM\03MYN1.SGM
03MYN1
]]>Agencies
[Federal Register Volume 89, Number 87 (Friday, May 3, 2024)]
[Notices]
[Page 36825]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09639]
[[Page 36825]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Epidemiology Cohorts (U01).
Date: June 4, 2024.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W110, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Priya Srinivasan, Ph.D., Scientific Review
Officer, Resource and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W110, Rockville, Maryland 20850, 240-276-5619,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-12: NCI Clinical and Translational Cancer Research.
Date: June 14, 2024.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W526, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Viktoriya Sidorenko, Ph.D., Scientific Review
Officer, Program and Review Extramural Staff Training Office,
Division of Extramural Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W526, Rockville, Maryland 20850,
240-276-5073, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Program Project (P01) Review SEP-C.
Date: June 17-18, 2024
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W634, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Michael E. Lindquist, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W634, Rockville, Maryland 20850,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-6: NCI Clinical and Translational Cancer Research.
Date: June 21, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W260, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Robert F. Gahl, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9606 Medical Center Drive, Room
7W260, Rockville, Maryland 20850, 240-276-7869, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-8: NCI Clinical and Translational Cancer Research.
Date: June 25, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W110, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Priya Srinivasan, Ph.D., Scientific Review
Officer, Resource and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W110, Rockville, Maryland 20850, 240-276-5619,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: April 29, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-09639 Filed 5-2-24; 8:45 am]
BILLING CODE 4140-01-P
